Literature DB >> 35691977

No difference in postoperative complication rates or cardiopulmonary function for early versus late scoliosis correction in Duchenne muscular dystrophy.

Ali Asma1, Armagan Can Ulusaloglu1, Michael Wade Shrader1, William G Mackenzie1, Robert Heinle2, Mena Scavina3, Jason J Howard4.   

Abstract

BACKGROUND: Given reduced rates of both pulmonary function decline and scoliosis progression with steroid treatment in Duchenne muscular dystrophy (DMD), the role of early scoliosis surgery has been questioned. The purpose of this study was to compare the postoperative complication rates of early versus late scoliosis correction in DMD.
METHODS: This study was a retrospective cohort, conducted at an academic tertiary level children's hospital. Patients with DMD who underwent posterior scoliosis correction, with preoperative pulmonary function testing [forced vital capacity (FVC)] were included and divided into two groups by preoperative curve angles: ≤ 45° and > 45°. The primary outcome variable was postoperative complications by Clavien-Dindo classification grading. Secondary outcome variables included postoperative complications occurring after the first 90 days, age at surgery, duration of wheelchair dependency preoperatively, pulmonary function, steroid utilization, shortening fraction by echocardiogram, surgery duration, intensive care unit/hospital length of stay, days intubated, infection, and percent curve correction. Two-tailed t-test and Chi-square testing were used for analysis of patient factors and Clavien-Dindo complication grade, respectively.
RESULTS: Thirty-one patients were included with a total follow-up of 8.3 ± 3.2 years, 4.8 ± 2.2 years post-spinal fusion. Steroid treatment (prednisone, deflazacort) was utilized for 21 (67.7%) patients. Primary curve correction was not different between groups (65.0% vs 71.4% [p = 0.37]). There were no significant differences in Clavien-Dindo classification grades between groups (p > 0.05). For the entire cohort, the overall complication rate was higher for patients with steroid treatment (61.9% vs 10.0% [p = 0.008]). Neither forced vital capacity nor fractional shortening on echocardiogram was different between groups at final follow-up (p = 0.6 and p = 0.4, respectively).
CONCLUSION: The comparable risk of perioperative complications for early and late scoliosis correction supports a "watchful waiting" approach, whereby curves less than 45° can be carefully followed while cardiopulmonary function is maintained. Patients undergoing steroid treatment should be counseled regarding the higher risk of postoperative blood transfusion and deep wound infection. LEVEL OF EVIDENCE: III Retrospective cohort.
© 2022. The Author(s), under exclusive licence to Scoliosis Research Society.

Entities:  

Keywords:  Clavien–Dindo classification; Duchenne muscular dystrophy; Postoperative complications; Pulmonary function; Scoliosis; Steroid treatment

Mesh:

Substances:

Year:  2022        PMID: 35691977     DOI: 10.1007/s43390-022-00532-6

Source DB:  PubMed          Journal:  Spine Deform        ISSN: 2212-134X


  27 in total

1.  Advantage of early spinal stabilization and fusion in patients with Duchenne muscular dystrophy.

Authors:  M D Sussman
Journal:  J Pediatr Orthop       Date:  1984-09       Impact factor: 2.324

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Benjamin A Alman; Susan D Apkon; Angela Blackwell; Laura E Case; Linda Cripe; Stasia Hadjiyannakis; Aaron K Olson; Daniel W Sheehan; Julie Bolen; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Scoliosis associated with Duchenne muscular dystrophy.

Authors:  W Cambridge; J C Drennan
Journal:  J Pediatr Orthop       Date:  1987 Jul-Aug       Impact factor: 2.324

4.  Spinal fusion in Duchenne muscular dystrophy.

Authors:  F Miller; C F Moseley; J Koreska
Journal:  Dev Med Child Neurol       Date:  1992-09       Impact factor: 5.449

5.  Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.

Authors:  Sylvie Houde; Michèle Filiatrault; Anne Fournier; Julie Dubé; Sylvie D'Arcy; Denis Bérubé; Yves Brousseau; Guy Lapierre; Michel Vanasse
Journal:  Pediatr Neurol       Date:  2008-03       Impact factor: 3.372

6.  Surgical stabilization of the spine in Duchenne muscular dystrophy.

Authors:  R L Weimann; D A Gibson; C F Moseley; D C Jones
Journal:  Spine (Phila Pa 1976)       Date:  1983-10       Impact factor: 3.468

7.  Longitudinal study of spinal deformity in Duchenne muscular dystrophy.

Authors:  T Oda; N Shimizu; K Yonenobu; K Ono; T Nabeshima; S Kyoh
Journal:  J Pediatr Orthop       Date:  1993 Jul-Aug       Impact factor: 2.324

8.  Spinal fusion in Duchenne muscular dystrophy--fixation and fusion to the sacropelvis?

Authors:  S J Mubarak; W D Morin; J Leach
Journal:  J Pediatr Orthop       Date:  1993 Nov-Dec       Impact factor: 2.324

9.  Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.

Authors:  J R Mendell; R T Moxley; R C Griggs; M H Brooke; G M Fenichel; J P Miller; W King; L Signore; S Pandya; J Florence
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

10.  Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.

Authors:  Eric P Hoffman
Journal:  Acta Myol       Date:  2020-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.